-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

114A.O2.6 114. Sickle Cell Disease, Sickle Cell Trait and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Building on Momentum in Disease-Modifying Therapeutics for Sickle Cell Disease

Symposia: Sickle cell Disease, Sickle Cell Trait and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Saturday, December 9, 2023: 4:00 PM-5:30 PM
Room 28 A-D (San Diego Convention Center)
Moderators:
Melissa Azul, DO, Medical College of Wisconsin and Venee Tubman, MD, Texas Children's Hospital
Disclosures:
No relevant conflicts of interest to declare.
4:00 PM

Modupe Idowu, MD1, Lucas Otieno, MD, MPH2*, Bogdan Dumitriu, MD3, Clarisse LC Lobo, MD, PhD4*, Swee Lay Thein, MD, DSc5*, Biree Andemariam, MD6, Obiageli E Nnodu, MD7, Adlette Inati, MD8, Alexander K Glaros, MD9*, Sara Teresinha Olalla Saad, MD10, Pablo Bartolucci, MD, PhD11*, Raffaella Colombatti, MD12, Ali T Taher, MD, PhD, FRCP13, Miguel R Abboud, MD14, Abdulafeez Oluyadi, PharmD15*, Varsha Iyer, PhD15*, Ophelia Yin, PhD16,17*, Susan Morris, PhD15*, Amber M Yates, MD15*, Hui Shao, PhD15*, Spurthi Patil15*, Rolandas Urbstonaitis, PharmD, MBS15*, Ahmar U Zaidi, MD15* and Wally R Smith, MD18

1McGovern Medical School, UTHealth, Houston, TX
2Victoria Biomedical Research Institute, Kisumu, Kenya
3Mid-Atlantic Permanente Medical Group, Largo, MD
4Research Division, HEMORIO, Rio de Janeiro, Brazil
5Sickle Cell Branch, The National Heart, Lung, and Blood Institute, Bethesda, MD
6New England Sickle Cell Institute, University of Connecticut Health, Farmington, CT
7Centre of Excellence for Sickle Cell Disease Research and Training, Department of Haematology and Blood Transfusion, College of Health Sciences, University of Abuja, Abuja, Nigeria
8Lebanese American University Gilbert and Rose-Marie Chagoury School of Medicine, Byblos and NINI Hospital, Tripoli, Lebanon
9Division of Hematology/Oncology, Children’s Hospital of Michigan, Detroit, MI
10Hematology and Transfusion Medicine Center - University of Campinas/Hemocentro-UNICAMP, Campinas, São Paulo, Brazil, University of Campinas (Unicamp), Campinas, Brazil
11Reference Center of Sickle Cell Disease, Mondor University Hospital, Créteil, France
12Pediatric Hematology Oncology Unit, University of Padova, Padova, Italy
13American University of Beirut Medical Center, Beirut, Lebanon
14Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon
15Agios Pharmaceuticals, Inc., Cambridge, MA
16iTeos Therapeutics, Watertown, MA
17At time of research, Agios Pharmaceuticals, Inc., Cambridge, MA
18Virginia Commonwealth University, Richmond, VA

4:15 PM

Miguel R Abboud, MD1, Rodolfo D Cançado, MD, PhD2*, Mariane De Montalembert, MD, PhD3, Wally R Smith, MD4, Hala Rimawi, FRCP5*, Ersi Voskaridou, MD6*, Birol Guvenc, MD7*, Deborah Keefe, MD, MPH8*, Kai Grosch9*, Michele L Nassin, MD8, Jimmy Watson, MD10*, Justin Yssel, PhD10*, Evgeniya Reshetnyak, PhD8* and Yvonne Dei Adomakoh, MBBS, MD11

1Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon
2Department of Hematology/Oncology, Hospital Samaritano – São Paulo, São Paulo, Brazil
3Department of General Pediatrics and Pediatric Infectious Diseases, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
4Division of General Internal Medicine, Department of Medicine, Virginia Commonwealth University, Richmond, VA
5Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan
6Thalassaemia Centre, Laikon General Hospital, Athens, Greece
7Department of Hematology, Medical Faculty, Cukurova University, Adana, Balcali, TUR
8Novartis Pharmaceuticals Corporation, East Hanover, NJ
9Novartis Pharma AG, Basel, Switzerland
10Global Health DU, Novartis Ireland Limited, Dublin, Ireland
11University of Ghana Medical School/Korle Bu Teaching Hospital, Accra, Greater Accra, Ghana

4:30 PM

Anna Conrey, NP1*, Ingrid Frey, RN1*, Nancy Asomaning, MS1*, Ruth Pierre Charles, DSc, PA-C2*, Dina Parekh, MD3*, Julia Xu, MD, MS1, Kang Le1*, Britney Kruah1*, Quan Li4*, Emily Dunkelberger5*, Troy Cellmer5*, Amber M Yates, MD6*, Megan Wind-Rotolo6*, Neal Jeffries, PhD7*, William A Eaton4* and Swee Lay Thein, MBBS, DSc, FRCP, FRCPath, MRCP, MRCPath8

1Sickle Cell Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD
2Sickle cell Branch, National Heart, Lung and Blood Institutes / National Institutes of Health, Bethesda, MD
3Sickle Cell Branch, National Heart, Lung and Blood Institutes / NIH, Bethesda, MD
4Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD
5Laboratory of Chemical Physics, NIDDK NIH, Bethesda, MD
6Agios Pharmaceuticals, Inc., Cambridge, MA
7Office of Biostatistics Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD
8Sickle Cell Branch, National Heart, Lung & Blood Institute, Bethesda, MD

4:45 PM

Santosh L. Saraf, MD1, Shehu Umar Abdullahi, MD2*, Adeseye Michael Akinsete, MBBS3*, Foluke A Fasola4*, Modupe Idowu, MD5, Sharon Pennington, MD6, William B Ershler, MD7, Marshall Patrick Stagg8*, Wai Chin9*, Eric Zimmerman9*, Adeyemi Adenola10*, Mira Patel Pochron9* and Eleanor A Lisbon, MD10

1Division of Hematology/Oncology, University of Illinois Chicago, Chicago, IL
2Department of Pediatrics, Bayero University/Aminu Kano Teaching Hospital, Kano, Nigeria
3College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria
4University of Ibadan/University College Hospital, Idi-Araba, Ibadan, Nigeria
5Department of Hematology and Oncology, The University of Texas Health Science Center McGovern Medical School, Houston, TX
6Mississippi Center For Advanced Medicine, Madison, MS
7Inova Schar Cancer Institute, Fairfax, VA
8Baton Rouge General Medical Center, Baton Rouge, LA
9Pfizer Inc, South San Francisco, CA
10Pfizer Inc, New York, NY

5:00 PM

Shubaya Kasule Naggayi, MSc1,2*, Dennis Kalibala2*, Robert Opoka, MBChB, PhD3,4*, Caterina Rosano, MD, MPH5*, Deogratias Munube, MD4*, Phillip Kasirye, MD4*, Ezekiel Mupere, MD, PhD4*, Vincent Mboizi2*, John Ssenkusu, PhD6*, Nancy S. Green, MD7, Richard Idro, PhD4* and Paul Bangirana, PhD8*

1Makerere University College of Health Sciences, Kampala, Uganda
2Global Health Uganda, Kampala, Uganda
3Department of Paediatrics and Child Health, College of Health Sciences, Makerere University, Kampala, Uganda
4Department of Pediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda
5Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA
6Department of Epidemiology and Biostatistics, Makerere University College of Health Sciences, Kampala, Uganda
7Department of Pediatrics, Division of Hematology, Oncology and Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY
8Department of Psychiatry, Makerere University College of Health Sciences, Kampala, Uganda

5:15 PM

Nirmish Shah, MD1, Girindra Raval, MBBS2, Abdullah Kutlar, MD3, Niren Patel, MBBS4*, Mayuko Takezaki4*, Biaoru Li, MD, PhD4*, Manickam Alagar, PhD4*, Hongyan Xu, PhD5*, Kelly Blackburn6*, Santhosh Vadivelu, PhD7, Robert Schaub, PhD7, David Santos7* and Betty Pace8

1Department of Medicine, Division of Hematology - Duke Sickle Cell Comprehensive Care Unit, Duke University Medical Center, Durham, NC
2Department of Medicine, Medical College of Georgia, Augusta, GA
3Medical College of Georgia, Augusta, GA
4Department of Medicine, Augusta University, Augusta, GA
5Department of Population Health Sciences, Augusta University, Augusta, GA
6AkiraBio, Wellesley, MA
7Akirabio, Wellesley, MA
8Augusta University, Augusta, GA

*signifies non-member of ASH